Tumor necrosis factor in colitis—bad actor or hero?
Investigators at Children's Hospital Los Angeles have found that a common therapeutic target for the treatment of inflammatory bowel disease (IBD) may actually protect against intestinal inflammation by inhibiting pathogenic ...
Sep 25, 2015
0
8